European Journal of Internal Medicine
Guideline-directed medical therapy and mortality in heart failure patients hospitalized for COPD exacerbation
Cohort study of 14,582 peopleGuideline-directed medical therapy
Angiotensin receptor-neprilysin inhibitors
Papers on angiotensin receptor-neprilysin inhibitors
45 papers28 new in 30 days
Monday, March 16
Thursday, October 23
JACC Advances
Patient Characteristics and Mortality Trends Among Octogenarians With Heart Failure: A Real-World Analysis
Cohort study of 46,943 peopleHeart failure
Friday, July 25
Expert Opinion on Drug Safety
Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting database
Cohort study in peopleSGLT2 inhibitors
Monday, March 10
JMIR Research Protocols
Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonists in Stable Patients With Heart Failure With Reduced Ejection Fraction (NovCon Sequencing Study): Protocol for a Randomized Controlled Trial
Study protocolSGLT2 inhibitors
Monday, January 20
ESC Heart Failure
Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort
Cohort study of 3,154 peopleHeart failure with reduced ejection fraction
Saturday, January 18
Tuesday, December 17
Journal of Clinical Medicine
An Observational Study of Evidence-Based Therapies in Older Patients with Heart Failure with Reduced Ejection Fraction: Insights from a Dedicated Heart Failure Clinic
Cohort study of 110 peopleHeart failure with reduced ejection fraction
Tuesday, July 30
Reviews in Cardiovascular Medicine
An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease
ReviewChronic kidney disease
Friday, March 8
Journal of the American Heart Association
Use of Sodium-Glucose Cotransporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real-World Data
Cohort study of 60,927 peopleAtrial fibrillation
Monday, October 23
Monday, August 21
Journal of Hypertension
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices
ReviewInterventions
Saturday, July 15
Tuesday, June 7
JACC Basic to Translational Science
Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
ReviewInterventions
Tuesday, November 16
European Cardiology
Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
ReviewHeart disease
Saturday, August 7
Journal of Cardiac Failure
New Drugs for Heart Failure: What is the Evidence in Older Patients?
ReviewHeart failure